wire - news in brief

« BACK

Life Sciences



Results 1 - 50 of 846.
1 2 3 4 5 ... 17 Next »


Life Sciences - Pharmacology - 16.04.2019
AveXis data reinforce effectiveness of Zolgensma in treating spinal muscular atrophy (SMA) Type 1
Ph 3 STR1VE data show prolonged event-free survival, early and rapid increases in CHOP-INTEND and significant milestone achievement in SMA Type 1, consistent with START trial   First-in-human biodist

Life Sciences - 10.04.2019
Showy Primates Have Smaller Testicles
Well-adorned or well-endowed ' but not both. Evolutionary biologists at the University of Zurich have for the first time demonstrated that male primates either have large testicles or showy ornaments. Developing both at the same time may simply take too much energy. Male primates are highly competitive, especially about one thing: fathering offspring.

Life Sciences - Careers / Employment - 08.04.2019
Interview with new group leader Guillaume Diss
Guillaume Diss joined the FMI as a new Quantitative Biology group leader on March 1. His research focuses on understanding the mechanisms whereby genetic variation translates into phenotypic variation - for example, in diseases.

Pharmacology - Life Sciences - 01.04.2019
AveXis expands world-leading gene therapy manufacturing capacity with purchase of advanced biologics therapy manufacturing campus in Longmont, Colorado
Facility to become the largest of four state-of-the-art sites involved in manufacturing of AveXis gene therapies for pipeline of rare genetic diseases including spinal muscular atrophy   AveXis plans

Physics - Life Sciences - 01.04.2019
Three EPFL professors awarded ERC Advanced Grants
Three EPFL professors awarded ERC Advanced Grants
Professors Pierre Gönczy and Douglas Hanahan (School of Life Sciences), and Professor Tobias J. Kippenberg (School of Basic Sciences/School of Engineering) have been awarded ERC Advanced Grants.

Life Sciences - Agronomy / Food Science - 25.03.2019
Corinne Boss Takes Reins of ’Animals and Products of Animal Origin’ Competence Division at Agroscope
Corinne Boss is the new Head of Agroscope's 'Animals and Products of Animal Origin' Competence Division for Research Technology and Knowledge Transfer; in this capacity, she also becomes a Member of the Agroscope Executive Board. A biologist and official expert in animal health, Corinne Boss currently works at the Swiss Federal Office for Agriculture (FOAG) as a Research Scientist in the 'Products of Animal Origin and Livestock Breeding' Division.

Life Sciences - 15.03.2019
Female roundworms produce clones of themselves
Female roundworms produce clones of themselves
In the Mesorhabditis belari roundworm, the sole purpose of males is to help females produce clones of themselves. This unique form of reproduction was recently described by an international research team with participation of Peter Meister from the Institute of Cell Biology of the University of Bern.

Life Sciences - Psychology - 13.03.2019
New Marie Curie and EMBO Fellows at the FMI
Five of our postdocs were recently awarded the prestigious EMBO and Maria Sklodowska-Curie Actions (MSCA) Fellowships.

Health - Life Sciences - 12.03.2019
EPFL software mines rich medical data while keeping it secure
MedCo , developed in the lab of EPFL professor Jean-Pierre Hubaux in collaboration with professor Bryan Ford 's DEDIS lab and the Lausanne University Hospital ( CHUV ), is the first operational system to protect sensitive patient data - including genetic information - so that it can be used collectively for crucial medical research.

Life Sciences - 11.03.2019

Life Sciences - Health - 27.02.2019
Model redefines the tree of life as we know it
Model redefines the tree of life as we know it
A new method shows that the relationships between living species, from bacteria to plants and animals, are different from previous estimates.

Health - Life Sciences - 27.02.2019
Bern Center for Precision Medicine founded
Bern Center for Precision Medicine founded
Precision medicine "tailored" to individual patients is regarded as the medicine of the future. It is already being practiced at the University of Bern and Inselspital, Bern University Hospital.

Life Sciences - 13.02.2019
7 challenges facing research and investment in primary brain tumours
Johanna Joyce, Ludwig member, co-signs a position paper on the challenges the scientific community faces in the fight against primary brain tumours On the initiative of Cancer Research UK, an international panel of brain cancer researchers and clinicians assessed the most important challenges ahead in the development of effective treatmens for patients.

Life Sciences - 11.02.2019

Life Sciences - 08.02.2019

Life Sciences - Environment - 30.01.2019
Urban biodiversity: Remarkable diversity of small animals in Basel gardens
Urban biodiversity: Remarkable diversity of small animals in Basel gardens
Gardens in urban areas can harbor a remarkable diversity of species. This has been found by researchers from the University of Basel in a field study carried out with the support of private garden owners from the Basel region. Furthermore, the research team shows that nature-friendly garden management and design can largely compensate for the negative effects of urbanization on biodiversity.

Life Sciences - Chemistry - 28.01.2019
How do mRNAs deal with stress?
Two hallmarks of the integrated stress response of cells are the inhibition of translation and the formation of stress granules (SGs) and processing bodies (PBs). However, it is not well understood how both processes are coupled. In a study published in Molecular Cell, researchers from the Chao group applied single-molecule RNA imaging to study the interactions of mRNAs with SGs and PBs, and found out that the generally accepted assumptions about the function of granules need to be revised.

Pharmacology - Life Sciences - 22.01.2019

Health - Life Sciences - 22.01.2019

Life Sciences - 21.01.2019
Octopus's Garden: The Stunning Life of Macroalgae
Octopus’s Garden: The Stunning Life of Macroalgae
The Botanical Garden of the University of Zurich is displaying large-format pictures of macroalgae taken by photographer Josh Westrich, bringing these maritime organisms into the tropical setting of UZH's greenhouses.

Health - Life Sciences - 15.01.2019

Environment - Life Sciences - 15.01.2019
EPFL goes to New Zealand to study melting glaciers
Four EPFL researchers will explore New Zealand's glacier-fed streams for two months, marking the first step in a global journey that will take them across 15 countries by 2021.

Life Sciences - 09.01.2019
Change of Teeth Causes Yo-Yo Effect in Elephants' Weight
Change of Teeth Causes Yo-Yo Effect in Elephants’ Weight
The weight of elephants living in zoos fluctuates over the course of their adult lives in cycles lasting around a hundred months, researchers at the University of Zurich have found. The fluctuation is linked to the particular pattern of tooth change in elephants, which results in them having more or less chewing surface available.

Life Sciences - Physics - 02.01.2019
Pushing the boundaries of the visible
Our cutting-edge technology platforms are key enablers of research at the FMI. One of the biggest of these, with the largest number of users, is the Facility for Advanced Imaging and Microscopy (FAIM). To find out more about the facility, and microscopy in general, we spoke to the joint heads of FAIM - Christel Genoud, who is responsible for Electron Microscopy, and Laurent Gelman, responsible for Light Microscopy.

Life Sciences - Environment - 10.12.2018
The Fascinating World of Insects
The Fascinating World of Insects
Highlighting diversity, arousing fascination and raising awareness of the vital tasks that insects perform in nature.

Life Sciences - Health - 23.11.2018
Rescue machinery prevents cellular suicide
Rescue machinery prevents cellular suicide
In a new study published in Science a team led by Prof. Petr Broz from the Department of Biochemistry identify a new mechanism to control immune cell death associated with inflammatory diseases, including sepsis, inflammatory bowel disease (IBD), and arthritis.

Life Sciences - 19.11.2018
Precise synaptic organization of a memory network
Precise synaptic organization of a memory network
In order to examine how synaptic inputs to individual neurons are organized in a distributed memory network, researchers from the Friedrich group performed electrophysiological recordings in the zebrafish homolog of the olfactory cortex. They found that large excitatory inputs were paired with large inhibitory inputs, which may seem counterintuitive because inhibition cancels excitation.

Environment - Life Sciences - 01.11.2018
Wyss Foundation supports the University of Bern
Wyss Foundation supports the University of Bern
The Wyss Foundation announced yesterday that it will begin a global conservation campaign. On a related note, they also announced that they will be working on a year-long pilot project in Kenya and Peru, together with the University of Bern.

Health - Life Sciences - 01.11.2018
Andrea Ablasser wins the 2018 National Latsis Prize
The medical researcher and EPFL professor Andrea Ablasser , who studies how cells defend themselves against viral and bacterial attacks, has won the 2018 National Latsis Prize in recognition of her excellent research work on immunity.

Life Sciences - 01.11.2018

Health - Life Sciences - 01.11.2018
Latsis Prize 2018: Andrea Ablasser unlocks the secret of rapid virus defence
Latsis Prize 2018: Andrea Ablasser unlocks the secret of rapid virus defence
The medical researcher and EPFL professor Andrea Ablasser studies how cells defend themselves against viral and bacterial attacks.

Health - Life Sciences - 30.10.2018
Switzerland-wide platform for cell therapy launched in Bern
Regenerative Medicine is one of the fastest growing sectors in biomedical research - replacing diseased cells, tissues or organs.

Life Sciences - Health - 26.10.2018
Subsides d’encouragement de projets de recherche FNS: 26 projets UNIL-CHUV acceptés - News
Subsides d'encouragement de projets de recherche FNS: 26 projets UNIL-CHUV acceptés Lors de la dernière session de printemps 2018, 26 projets de recherche UNIL-CHUV ont été financés par le FNS.

Health - Life Sciences - 24.10.2018

Life Sciences - Health - 23.10.2018
The epigenetics of cartilage repair and regeneration
The European Research Council (ERC) has awarded a prestigious ERC Synergy Grant - perhaps the most competitive funding scheme from ERC - to the research groups of Prof. Filippo Rijli from the

Health - Life Sciences - 19.10.2018
Novartis phase II GEOMETRY mono-1 trial of investigational medicine capmatinib (INC280) shows positive results in patients with MET mutated advanced NSCLC
Novartis phase II GEOMETRY mono-1 trial of investigational medicine capmatinib (INC280) shows positive results in patients with MET mutated advanced NSCLC Phase II study efficacy data showed overall response rate of 72.0% and 39.1%, respectively, in treatment-naive and previously treated patients with advanced MET exon-14 skipping mutated non-small cell lung cancer (NSCLC)   Clinical findings from ongoing study indicate safety prof

Health - Life Sciences - 16.10.2018
Novartis 5-year data in psoriatic arthritis and ankylosing spondylitis reinforces Cosentyx leadership in spondyloarthritis
Data from the MEASURE 1 and FUTURE 1 studies show rapid and long-lasting sustained improvement in the signs and symptoms of ankylosing spondylitis (AS) and psoriatic arthritis (PsA) ,   In rheumatolo

Health - Life Sciences - 10.10.2018
Novartis announces new data from the first direct head-to-head trial to demonstrate superior efficacy of Gilenya over Copaxone in patients with relapsing remitting multiple sclerosis
Topline findings from ASSESS show adult relapsing remitting multiple sclerosis (RRMS) patients taking Gilenya (fingolimod) 0.5mg experienced significantly fewer relapses than patients on Copaxone (glatiramer acetate) 20mg   Gilenya 0.5mg is the first and only disease modifying therapy to show superiority in reducing relapses vs Copaxone in a controlled, head-to-head trial   Treatment discontinuations were overall more common in the

Health - Life Sciences - 08.10.2018
Novartis announces FDA and EMA filing acceptance of siponimod, the first and only drug shown to meaningfully delay disability progression in typical SPMS patients
There is a critical need for safe and effective treatments for secondary progressive multiple sclerosis (SPMS) - a highly debilitating form of MS characterized by gradual, irreversible worsening of d
1 2 3 4 5 ... 17 Next »